K.S. Grzankowski

434 total citations
17 papers, 241 citations indexed

About

K.S. Grzankowski is a scholar working on Reproductive Medicine, Cancer Research and Oncology. According to data from OpenAlex, K.S. Grzankowski has authored 17 papers receiving a total of 241 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Reproductive Medicine, 5 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in K.S. Grzankowski's work include Ovarian cancer diagnosis and treatment (7 papers), BRCA gene mutations in cancer (2 papers) and Endometrial and Cervical Cancer Treatments (2 papers). K.S. Grzankowski is often cited by papers focused on Ovarian cancer diagnosis and treatment (7 papers), BRCA gene mutations in cancer (2 papers) and Endometrial and Cervical Cancer Treatments (2 papers). K.S. Grzankowski collaborates with scholars based in United States and Canada. K.S. Grzankowski's co-authors include Kevin H. Eng, Kirsten B. Moysich, Kunle Odunsi, Kelly L. Singel, Brahm H. Segal, A. Nazmul H. Khan, Michael E. Carney, Shashi Lele, Michael A. Black and Keith Y. Terada and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Oncotarget.

In The Last Decade

K.S. Grzankowski

16 papers receiving 238 citations

Peers

K.S. Grzankowski

IMMUN

ONCOL

Kotaro Shimura Japan

Beata Maćkowiak-Matejczyk Poland

Patricia Evans United Kingdom

Marcin Jędryka Poland

Claudia Lefeuvre‐Plesse France

Soizick Mesnage France

Irina Tsibulak Austria

Vilius Rudaitis Lithuania

Maud Jonnaert United States

Youguo Chen China

Kotaro Shimura Japan

K.S. Grzankowski

179 ×1.6

IMMUN

212 ×2.1

ONCOL

58 ×0.8

64 ×1.7

81 ×2.3

Citations per year, relative to K.S. Grzankowski K.S. Grzankowski (= 1×) peers Kotaro Shimura

Countries citing papers authored by K.S. Grzankowski

Since Specialization

Citations

This map shows the geographic impact of K.S. Grzankowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K.S. Grzankowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K.S. Grzankowski more than expected).

Fields of papers citing papers by K.S. Grzankowski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K.S. Grzankowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K.S. Grzankowski. The network helps show where K.S. Grzankowski may publish in the future.

Co-authorship network of co-authors of K.S. Grzankowski

This figure shows the co-authorship network connecting the top 25 collaborators of K.S. Grzankowski. A scholar is included among the top collaborators of K.S. Grzankowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K.S. Grzankowski. K.S. Grzankowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Recio, Fernando O., Brian Orr, Young Kwang Chae, et al.. (2023). Immunotherapy response monitoring using personalized circulating tumor DNA analysis in patients with relapsed gynecologic malignancies (2297). Gynecologic Oncology. 176. S313–S314. 1 indexed citations

Grzankowski, K.S., Concepcion Diaz‐Arrastia, Georges Azzi, et al.. (2022). ctDNA in treatment response monitoring in patients with relapsed gynecologic malignancies.. Journal of Clinical Oncology. 40(16_suppl). e17501–e17501.

Handel, Emile Van, Kevin H. Eng, K.S. Grzankowski, et al.. (2018). Docetaxel and nab-paclitaxel are safe alternative options for patients with gynecologic malignancies following hypersensitivity reaction to paclitaxel.. PubMed. 37(6). 800–802. 1 indexed citations

Szender, J. Brian, K.S. Grzankowski, Kevin H. Eng, Kunle Odunsi, & Peter J. Frederick. (2016). Evaluation of satisfaction with work–life balance among U.S. Gynecologic Oncology fellows: A cross-sectional study. Gynecologic Oncology Reports. 16. 17–20. 7 indexed citations

Grzankowski, K.S., et al.. (2016). The CD47 “don't eat me signal” is highly expressed in human ovarian cancer. Gynecologic Oncology. 143(2). 393–397. 60 indexed citations

Grzankowski, K.S., et al.. (2016). Evaluation of Metachronous Breast and Endometrial Cancers. International Journal of Gynecological Cancer. 26(8). 1440–1447. 4 indexed citations

Szender, J. Brian, K.S. Grzankowski, Stacey N. Akers, et al.. (2016). Evaluation of the impact of chronic steroid use on outcomes in gynecologic cancer patients: A NSQIP database analysis. Gynecologic Oncology. 141. 169–169. 1 indexed citations

Eng, Kevin H., A. Nazmul H. Khan, K.S. Grzankowski, et al.. (2015). Cytokine profiling of ascites at primary surgery identifies an interaction of tumor necrosis factor-α and interleukin-6 in predicting reduced progression-free survival in epithelial ovarian cancer. Gynecologic Oncology. 138(2). 352–357. 71 indexed citations

Szender, J. Brian, Gary Zirpoli, Albina N. Minlikeeva, et al.. (2015). Oral Contraceptive Use and Reproductive Characteristics Affect Survival in Patients With Epithelial Ovarian Cancer. International Journal of Gynecological Cancer. 25(9). 1587–1592. 7 indexed citations

10.

Grzankowski, K.S., et al.. (2015). Poorly differentiated Sertoli–Leydig tumor with heterologous, high-grade, sarcomatoid features: A case report. SHILAP Revista de lepidopterología. 14. 6–8. 1 indexed citations

11.

Grzankowski, K.S., Jasmine Kaur, Samantha Poblete, et al.. (2015). Higher than expected frequencies of non-ovarian cancers within a large familial ovarian cancer registry.. PubMed. 2(1). 39–44. 1 indexed citations

12.

Minlikeeva, Albina N., Jo L. Freudenheim, Wei-Hsuan Lo-Ciganic, et al.. (2015). Use of Common Analgesics Is Not Associated with Ovarian Cancer Survival. Cancer Epidemiology Biomarkers & Prevention. 24(8). 1291–1294. 5 indexed citations

13.

Khan, A. Nazmul H., Kelly L. Singel, Melissa Grimm, et al.. (2015). Targeting myeloid cells in the tumor microenvironment enhances vaccine efficacy in murine epithelial ovarian cancer. Oncotarget. 6(13). 11310–11326. 37 indexed citations

14.

Grzankowski, K.S., et al.. (2014). Malignant peritoneal mesothelioma without asbestos exposure: An ovarian cancer imitator. Gynecologic Oncology Reports. 11. 10–12. 2 indexed citations

15.

Grzankowski, K.S., David Shimizu, Chieko Kimata, Michael A. Black, & Keith Y. Terada. (2012). Clinical and pathologic features of young endometrial cancer patients with loss of mismatch repair expression. Gynecologic Oncology. 126(3). 408–412. 22 indexed citations

16.

Grzankowski, K.S. & Michael E. Carney. (2011). Quality of Life in Ovarian Cancer. Cancer Control. 18(1). 52–58. 18 indexed citations

17.

Grzankowski, K.S. & Michael E. Carney. (2011). Quality of Life in Ovarian Cancer. Cancer Control. 18(1). 52–58. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact